দেশ: ইস্রায়েল
ভাষা: ইংরেজি
সূত্র: Ministry of Health
VERAPAMIL HYDROCHLORIDE
TRUSTPHARM LTD, ISRAEL
C08DA01
FILM COATED TABLETS
VERAPAMIL HYDROCHLORIDE 40 MG
PER OS
Required
S.C. AC HELCOR S.R.L., ROMANIA
VERAPAMIL
Cordamil is indicated for treatment of coronary heart disease, including:- chronic stable angina pectoris (effort angina), - unstable angina pectoris: - aggravated angina, resting angina, vasospastic angina (Prinzmetal angina) - post heart-attack angina in patients without heart failure, when adrenergic beta-blockers are contraindicated. Prevention of ventricular fast heart rate disorders not controlled by tonic-cardiac glycosides or beta-blockers (for example supraventricular paroxysmal tachycardia, atrial fibrillation/ flutter with rapid ventricular response, except for Wolff-Parkinson-White syndrome.) Moderate to mild essential hypertension
2022-03-10
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS (PREPARATIONS) - 1986 This medicine is dispensed with a doctor's prescription only CORDAMIL 40 MG CORDAMIL 80 MG FILM-COATED TABLETS ACTIVE INGREDIENT Cordamil 40 mg: Each tablet contains 40 mg verapamil hydrochloride Cordamil 80 mg: Each tablet contains 80 mg verapamil hydrochloride Inactive ingredients and allergens: see section 2 under ‘Important information about some of this medicine’s ingredients’, and section 6 ‘Additional information'. Read the entire leaflet carefully before you start using this medicine. This leaflet contains concise information about this medicine. If you have any further questions, consult your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if it seems to you that their medical condition is similar to yours. 1. WHAT IS THIS MEDICINE INTENDED FOR? 1. Cordamil is used for treatment of coronary heart disease, including: - chronic stable angina pectoris (effort angina); - unstable angina pectoris: - aggravated angina, resting angina, vasospastic angina (Prinzmetal angina adrenergic); - post-heart attack angina in patients without heart failure, when beta-blockers are contraindicated; 2. Prevention of ventricular fast heart rate disorders not controlled by Cardiac glycosides with cardiotonic effector beta-blockers (for example supraventricular paroxysmal tachycardia, atrial fibrillation/flutter with rapid ventricular response, except for Wolff- Parkinson-White syndrome). 3. Treatment of moderate to mild blood pressure. THERAPEUTIC GROUP: selective calcium channel blockers, calcium blockers with direct cardiac effects, phenylalkylamines. 2. BEFORE USING THIS MEDICINE DO NOT USE THIS MEDICINE IF: - you are sensitive (allergic) to the active ingredients or to any of the other ingredients in this medicine (listed in section 6). - you have cardiogenic shock. - you had an acute myocardial infarction with complications such as a slower heartbeat (bradycardi সম্পূর্ণ নথি পড়ুন
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT CORDAMIL 40 mg film-coated tablets CORDAMIL 80 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION CORDAMIL 40 mg Each film-coated tablet contains 40 mg verapamil hydrochloride. Excipients: lactose monohydrate 35.60 mg, tartrazine (E 102) 0.002 mg. CORDAMIL 80 mg Each film-coated tablet contains 80 mg verapamil hydrochloride. Excipients: lactose monohydrate 71.20 mg, tartrazine (E 102) 0.015 mg. For the list of all excipients, see point 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet CORDAMIL 40 mg Film-coated, light yellow lenticular tablets with a uniform appearance, compact and homogeneous structure, intact edges, engraved on one of the sides "V 40", with a diameter of 7 mm. CORDAMIL 80 mg Film-coated tablets, yellow lenticular with uniform appearance, compact and homogeneous structure, intact edges, engraved with "V 80" on one side and breaking line on the other, with a diameter of 9 mm. The breaking line is intended to ease swallowing of the tablet and not for dose modification (equivalence of the two parts was not demonstrated). 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of coronary heart disease, including: - chronic stable angina pectoris (effort angina), - unstable angina pectoris: - aggravated angina, resting angina, vasospastic angina (Prinzmetal angina), - post heart-attack angina in patients without heart failure, when - adrenergic beta- blockers are contraindicated. Prevention of ventricular fast heart rate disorders not controlled by tonic-cardiac glycosides or beta-blocker (for example supraventricular paroxysmal tachycardia, atrial fibrillation/flutter with rapid ventricular response, except for Wolff-Parkinson-White syndrome). Moderate to mild essential hypertension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dose of verapamil hydrochloride should be adjusted individually according to the severity of the condition. Long-term clinical experience demonstrates that the average dose for all indica সম্পূর্ণ নথি পড়ুন